Decade-long US project to fight malaria builds thriving African mosquito net industrySeptember 17, 2009In a decade-long initiative to protect millions of families from malaria in sub-Saharan Africa, a U.S. government-funded project helped sell 50 million bed nets in seven countries, crafted a voucher system to allow the poor to receive them for free or partial cost, and created enough incentives for private companies that they invested $88 million to expand their businesses, according to results released today by AED at a conference held at the National Press Club. This new commercial approach also helped reduce the price of insecticide-treated mosquito nets by 30 to 70 percent. Now, those nets sell for between US$4 and US$7. The NetMark project, a $67 million, USAID-funded public-private partnership to prevent malaria, ends September 30, but the bed net market continues to thrive in seven countries where it operated-Nigeria, Senegal, Mali, Ghana, Uganda, Ethiopia, and Zambia. Not only did the U.S. investment help spur major spending by private companies-for every $1 in public funds, African and international businesses spent $1.30-the new commercial sector now exists. "We worked ourselves out of a job. They don't need us anymore, and I'm proud of that," said Juan Manuel Urrutia, AED's Johannesburg-based deputy director of NetMark. "There are now 41 African distributors who will continue to sell thousands or millions of nets in those seven countries. The voucher system is now entrenched." Malaria, a preventable and treatable disease, is one of the biggest killers of young children in Africa. Overall, the disease, which is transmitted by mosquitoes, kills an estimated 1 million people annually, the vast majority of them in Africa. One of the most effective preventive measures against malaria is to sleep under insecticide-treated bed nets, which are a finely woven barrier and kill most mosquitoes upon contact. NetMark, which started in 1999, worked like this: It formed partnerships with international net and insecticide manufacturers and African distributors to create retail markets. Under NetMark, all parties worked together to launch the commercial marketing of insecticide-treated nets, or ITNs. The distributors put the nets into retail outlets. And the stores, most of which hadn't been selling bed nets, soon found a demand for them in part because of NetMark's national awareness campaigns on the benefits of using insecticide-treated nets. Later, NetMark created a discount voucher system in which people who could not afford the nets brought the voucher to a retailer, who was later reimbursed by the program. It fulfilled two goals-making sure families in poverty would get the nets for free or low cost, and the storeowner's business was not undercut. The results were indisputable. Two examples: Awareness of insecticide-treated nets among Ugandan women grew from 23 percent in 2000 to 98 percent in 2006; and 2.1 million African families used a voucher for a net from a commercial outlet. Other groups, embracing the concept, started voucher systems of their own. "Before NetMark began, families could not go to the market and buy a life-saving insecticide-treated net, and now they can," said AED President Stephen F. Moseley. "This program made treated nets easily accessible to everyone." Admiral Timothy Ziemer, U.S. Malaria Coordinator, said the project helped build a "culture" of bed net use. "U.S. investments through NetMark contributed to dramatically expanding the availability and use of insecticide-treated mosquito nets in Africa," he said. An estimated 70 to 80 percent of all bed nets in Africa are giveaways, according to studies. AED's experience shows, though, that a commercial market can thrive side-by-side with public handouts, becoming an important complement to the free distribution. Not only does the market offer choice of different types of nets to Africans who can afford them, but analysts believe it is vitally important to keep the market alive: It creates a new commercial sector and it provides a backup system for net distribution if donors' funding drops due to the current global financial crisis or to other emerging health threats. "One thing we have learned again and again in public health is that if you have a couple of approaches and strategies, it's a lot better than to have only one," said Professor Christian Lengeler, head of the Heath Interventions Unit at the Swiss Tropical Institute, an independent academic foundation. Lengeler and others believe that the AED-NetMark model in establishing a commercial distribution system for bed nets-supported by direct sales and with vouchers-can be replicated to fight other public health challenges. Jeffrey L. Sturchio, President and CEO of the Global Health Council, praised the initiative for creating a model that will last. "This project shows the surprising results that come from combining creativity, commitment, and commercial innovation on global health issues," he said. "It also shows that novel partnerships, bringing the public and private sectors together, can achieve impressive improvements in public health in a way that is reliable and sustainable." Academy for Educational Development |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||